Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants.
鼻内给药广谱大环肽抑制剂可预防SARS-CoV-2 Omicron变异株感染。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-68462-9
Wang Min, Yang Jinyue, Tan Yahong, Yuan Shuofeng, Shi Guoli, Peng Qi, Li Yongqi, Poon Vincent Kwok-Man, Chan Chris Chung-Sing, Xiao Na, Zhang Anna Jinxia, Xie Yubin, Li Junhua, Luo Hao, Fu Yaning, Chen Yong, Compton Alex A, Zhang Youming, Yang Yang, Gao George Fu, Hou Hongwei, Chan Jasper Fuk-Woo, Yin Yizhen, Shi Yi
